BioScrip Trading Up 7.7% After Strong Earnings (BIOS)
BioScrip (NASDAQ:BIOS) was up 7.7% during mid-day trading on Thursday following a better than expected earnings announcement, AnalystRatings.Net reports. The stock traded as high as $8.37 and last traded at $8.01, with a volume of 1,671,120 shares trading hands. The stock had previously closed at $7.44.
The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. The company had revenue of $247.10 million for the quarter, compared to the consensus estimate of $233.70 million. During the same quarter in the previous year, the company posted $0.04 earnings per share. The company’s revenue for the quarter was up 43.4% on a year-over-year basis.
The stock has a 50-day moving average of $7.68 and a 200-day moving average of $7.60. The company’s market cap is $544.0 million.
BioScrip, Inc (NASDAQ:BIOS) is a provider of pharmacy and home health services, which partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and the delivery of prescription medications and home health services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.